Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

Effect Of CP-690,550 On The Pharmacokinetics Of Metformin In Healthy Volunteers

Phase 1

Completed

Conditions: Rheumatoid Arthritis

Interventions: Drug: Metformin/CP-690,550

First Posted Date: 2011-07-29

Last Posted Date: 2011-08-18

Lead Sponsor: Pfizer

Target Recruit Count: 24

Registration Number: NCT01405118

Locations: 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium

A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets Under Fasting Conditions

Phase 1

Withdrawn

Conditions: Therapeutic Equivalency

Interventions: Drug: methylprednisolone

First Posted Date: 2011-07-29

Last Posted Date: 2018-10-23

Lead Sponsor: Pfizer

Registration Number: NCT01405157

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

Phase 1

Completed

Conditions: Chronic Lymphocytic Leukemia
Mantle Cell Lymphoma
Acute Myeloid Leukemia
Myelodysplastic Syndrome

Interventions: Drug: BMN 673

First Posted Date: 2011-07-22

Last Posted Date: 2017-09-15

Lead Sponsor: Pfizer

Target Recruit Count: 33

Registration Number: NCT01399840

Locations: 🇺🇸
University of Wisconsin, Madison, Wisconsin, United States
🇬🇧
University of Newcastle Upon Tyne, NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
🇺🇸
Indiana University Simon Cancer Center, Indianapolis, Indiana, United States

and more 4 locations

A Bioequivalence Study Comparing A Fixed Dose Combination Formulation Of Myrin P Forte That Contains Rifampicin, Isoniazid, Ethambutol And Pyrazinamide Per Tablet To An Equivalent Dose Of Single Drug Reference Preparations Of Similar Combination Following Oral Administration In Healthy Adults

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: Myrin P Forte
Drug: Single drug references

First Posted Date: 2011-07-22

Last Posted Date: 2017-04-05

Lead Sponsor: Pfizer

Target Recruit Count: 36

Registration Number: NCT01399788

Locations: 🇸🇬
Pfizer Investigational Site, Singapore, Singapore

A Study of PF-05175157 in Healthy Volunteers and Type 2 Diabetic Patients

Phase 1

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: PF-05175157 or Placebo

First Posted Date: 2011-07-18

Last Posted Date: 2016-11-06

Lead Sponsor: Pfizer

Target Recruit Count: 64

Registration Number: NCT01396161

Locations: 🇺🇸
MRA Clinical Research, South Miami, Florida, United States
🇺🇸
Miami Research Associates, South Miami, Florida, United States
🇺🇸
Pulmonary Physicians of South Florida, South Miami, Florida, United States

A Phase 1 Study To Investigate The Pharmacokinetics, Safety And Tolerability Of CP-601,927 In Healthy Japanese Subjects

Phase 1

Withdrawn

Conditions: Healthy

Interventions: Drug: CP-601,927
Drug: Placebo

First Posted Date: 2011-07-18

Last Posted Date: 2018-10-30

Lead Sponsor: Pfizer

Registration Number: NCT01396135

Safety and Tolerability of Ascending Intravenous Doses of PF-05231023 In Adult Subjects With Type 2 Diabetes

Phase 1

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: PF-05231023
Other: Placebo

First Posted Date: 2011-07-18

Last Posted Date: 2015-01-12

Lead Sponsor: Pfizer

Target Recruit Count: 50

Registration Number: NCT01396187

Locations: 🇺🇸
Pfizer Investigational Site, San Antonio, Texas, United States

Safety Surveillance of Pneumococcal 13-valent Conjugate Vaccine Among Filipinos

Completed

Conditions: Pneumococcal Disease

Interventions: Biological: Prevenar 13

First Posted Date: 2011-07-18

Last Posted Date: 2017-01-30

Lead Sponsor: Pfizer

Target Recruit Count: 3006

Registration Number: NCT01396434

Locations: 🇵🇭
Villanueva Laboratory and Clinics, Bacolod City, Philippines
🇵🇭
San Carlos Doctor's Hospital, San Carlos City, Negros Occidental, Philippines
🇵🇭
Private Clinic, Zamboanga City, Philippines

and more 65 locations

A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor

Phase 2

Completed

Conditions: Gastrointestinal Stromal Tumors

Interventions: Drug: sunitinib malate dose escalation
Drug: sunitinib malate

First Posted Date: 2011-07-18

Last Posted Date: 2019-03-27

Lead Sponsor: Pfizer

Target Recruit Count: 6

Registration Number: NCT01396148

Locations: 🇺🇸
Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, California, United States
🇨🇿
Fakultni nemocnice Brno, Brno, Czechia
🇨🇿
FN Brno, Brno, Czechia

and more 6 locations

Study to Assess the Concentration of Avibactam and Ceftazidime in Epithelial Lining Fluid and Plasma

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: CAZ104

First Posted Date: 2011-07-15

Last Posted Date: 2017-09-01

Lead Sponsor: Pfizer

Target Recruit Count: 45

Registration Number: NCT01395420

Locations: 🇬🇧
Research Site, London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy